We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5076:TSEINFRONEER Holdings Inc. Analysis

Data as of 2026-06-06 - not real-time

¥2,545.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

INFRONEER Holdings trades at ¥2,545.5, delivering a trailing P/E of 9.86—far below the industry average of 30.19—while its price‑to‑book sits at 1.05 and price‑to‑sales at 0.57, suggesting a cheap valuation on traditional multiples. The company’s revenue surged 46.5% YoY and it generates a solid ROE of 13.2% with a dividend yield of 3.93% and a payout ratio of 46.5%, making the dividend appear sustainable. However, the discounted cash‑flow model pins a fair value near ¥1,732, implying the current market price is significantly elevated and leaves little upside beyond the modest 0.74% upside estimate. The balance sheet shows ¥360 B of cash against ¥613 B of debt, yielding a debt‑to‑equity of 95, which raises leverage concerns despite ample liquidity. Free cash flow of ¥19 B supports dividend payments but the high leverage tempers the optimism.
On the technical side, the 20‑day SMA (2,413) sits below the market price and the MACD line remains bullish over its signal, while the RSI of 66.5 hints at nearing overbought conditions. Volatility is high at 37.5% over the past 30 days but beta is essentially neutral (‑0.006), and volume has been trending down, which could temper short‑term momentum as the stock approaches its resistance around ¥2,571. The stock’s 20‑day SMA (2,413) and 50‑day SMA (2,267) are both well under the current price, confirming a bullish trend, yet the decreasing volume and a max drawdown of 22.4% signal potential volatility. The Fear & Greed Index at 83 (Extreme Greed) reflects strong market sentiment, which could reverse if earnings miss expectations. Overall, the blend of attractive valuation multiples and solid dividend income is offset by leverage and a limited upside horizon, suggesting a cautious but not defensive stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI approaching overbought
  • Proximity to resistance at ¥2,571
  • Decreasing volume indicating waning momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 46.5% revenue growth
  • Trailing P/E 9.86 vs industry 30.19
  • Dividend yield 3.93% with sustainable payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage (debt‑to‑equity 95)
  • Strong cash generation and dividend income
  • Limited upside per DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth46.50%
Profit Margin6.81%
P/E Ratio9.9
ROE13.16%
ROA2.21%
Debt/Equity95.00
P/B Ratio1.0
Op. Cash Flow¥192.8B
Free Cash Flow¥19.1B
Industry P/E30.2

Technical Analysis

TrendBullish
RSI66.5
Support¥2,266.50
Resistance¥2,571.50
MA 20¥2,413.20
MA 50¥2,267.04
MA 200¥2,031.41
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair Value¥1,732.50
Target Price¥2,564.29
Upside/Downside0.74%
GradeFair
TypeBlend
Dividend Yield3.93%

Risk Assessment

Beta-0.01
Volatility37.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.